Q4 2018 Holdings
Filed 2019-02-13 | 203 holdings | $254.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biogen Inc.(BIIB) | Common | 09062X103 | $118.8M | 394,902 | 46.8% |
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $45.4M | 492,078 | 17.9% |
| BioMarin Pharmaceutical Inc.(BMRN) | Common | 09061G101 | $17.7M | 207,434 | 7.0% |
| Boston Scientific Corporation(BSX) | Common | 101137107 | $15.7M | 444,991 | 6.2% |
| BeiGene, Ltd.(ONC) | Sponsored ADR | 07725L102 | $12.0M | 85,755 | 4.7% |
| Alnylam Pharmaceuticals, Inc.(ALNY) | Common | 02043Q107 | $9.2M | 126,176 | 3.6% |
| Align Technology, Inc.(ALGN) | Common | 016255101 | $6.3M | 29,860 | 2.5% |
| Acadia Pharmaceuticals Inc.(ACHC) | Common | 00404A109 | $4.5M | 173,155 | 1.8% |
| Cellectis SA(CLLS) | Sponsored ADR | 15117K103 | $3.9M | 236,530 | 1.6% |
| Bausch Health Companies Inc.(BHC) | Common | 071734107 | $3.5M | 192,000 | 1.4% |
| Coherus Biosciences, Inc.(CHRS) | Common | 19249H103 | $2.9M | 315,162 | 1.1% |
| Ascendis Pharma A/S(ASND) | Sponsored ADR | 04351P101 | $2.7M | 42,399 | 1.0% |
| Charles River Laboratories International, Inc.(CRL) | Common | 159864107 | $2.6M | 22,670 | 1.0% |
| Agios Pharmaceuticals, Inc.(AGIO) | Common | 00847X104 | $2.3M | 49,025 | 0.9% |
| Adaptimmune Therapeutics plc(ADAPY) | Sponsored ADR | 00653A107 | $1.3M | 228,496 | 0.5% |
| Akebia Therapeutics, Inc.(AKBA) | Common | 00972D105 | $1.2M | 213,942 | 0.5% |
| Ardelyx, Inc.(ARDX) | Common | 039697107 | $1.1M | 639,370 | 0.5% |
| Community Health Systems, Inc.(CYH) | Common | 203668108 | $575.0K | 203,935 | 0.2% |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | Common | 04280A100 | $381.0K | 30,700 | 0.1% |
| Johnson & Johnson(JNJ) | Common | 478160104 | $133.3K | 1,032,628 | 0.1% |
| Amgen Inc.(AMGN) | Common | 031162100 | $132.0K | 677,855 | 0.1% |
| Gilead Sciences, Inc.(GILD) | Common | 375558103 | $118.2K | 1,889,846 | 0.0% |
| Unitedhealth Group Incorporated(UNH) | Common | 91324P102 | $93.5K | 375,374 | 0.0% |
| Celgene Corporation(CELG) | Common | 151020104 | $88.6K | 1,382,006 | 0.0% |
| Illumina, Inc.(ILMN) | Common | 452327109 | $78.7K | 262,379 | 0.0% |
| Vertex Pharmaceuticals Incorporated(VRTX) | Common | 92532F100 | $70.6K | 426,248 | 0.0% |
| Pfizer Inc.(PFE) | Common | 717081103 | $66.2K | 1,516,793 | 0.0% |
| Merck & Co., Inc.(MRK) | Common | 58933Y105 | $56.4K | 738,108 | 0.0% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common | 75886F107 | $51.0K | 136,422 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common | 015351109 | $48.3K | 496,288 | 0.0% |
| Medtronic plc(MDT) | Shares | G5960L103 | $43.8K | 481,365 | 0.0% |
| Thermo Fisher Scientific Inc.(TMO) | Common | 883556102 | $42.9K | 191,895 | 0.0% |
| Incyte Corporation(INCY) | Common | 45337C102 | $41.0K | 645,442 | 0.0% |
| Mylan N.V. | Shares | N59465109 | $38.5K | 1,403,728 | 0.0% |
| Anthem, Inc.(ELV) | Common | 036752103 | $37.1K | 141,147 | 0.0% |
| Bristol-Myers Squibb Company(BMY) | Common | 110122108 | $33.9K | 652,966 | 0.0% |
| Allergan plc | Shares | G0177J108 | $31.4K | 234,720 | 0.0% |
| CVS Health Corporation(CVS) | Common | 126650100 | $30.2K | 460,698 | 0.0% |
| Abbott Laboratories(ABT) | Common | 002824100 | $28.3K | 391,719 | 0.0% |
| Stryker Corporation(SYK) | Common | 863667101 | $25.1K | 160,432 | 0.0% |
| Eli Lilly and Company(LLY) | Common | 532457108 | $25.0K | 216,442 | 0.0% |
| Novartis AG(NVSN) | Sponsored ADR | 66987V109 | $25.0K | 291,717 | 0.0% |
| Danaher Corporation(DHR) | Common | 235851102 | $21.6K | 209,371 | 0.0% |
| Zoetis Inc.(ZTS) | Class A | 98978V103 | $21.5K | 251,415 | 0.0% |
| Sarepta Therapeutics, Inc.(SRPT) | Common | 803607100 | $20.9K | 191,837 | 0.0% |
| Humana Inc.(HUM) | Common | 444859102 | $19.6K | 68,487 | 0.0% |
| Centene Corporation(CNC) | Common | 15135B101 | $19.2K | 166,869 | 0.0% |
| Intuitive Surgical, Inc.(ISRG) | Common | 46120E602 | $18.8K | 39,229 | 0.0% |
| Teva Pharmaceutical Industries Limited(TEVA) | Sponsored ADR | 881624209 | $18.7K | 1,211,868 | 0.0% |
| AstraZeneca PLC(AZN) | Sponsored ADR | 046353108 | $16.3K | 428,024 | 0.0% |